Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Fakra

Showing results (11-20 of 92) with videos related to

Pageof 10
Sort By:
L'Encephale|August 7, 2007
[Conceptualisation and validation of the "Emotional State Questionnaire (ESQ)": evaluation of an emotional profile]C Cassé-Perrot, E Fakra, E Jouve, et al.
L'Encephale|January 19, 2016
[Negative symptoms: clinical and psychometric aspects]M Adida, J-M Azorin, R Belzeaux, et al.
L'Encephale|January 19, 2016
[Negative symptoms, emotion and cognition in schizophrenia]E Fakra, R Belzeaux, J-M Azorin, et al.
L'Encephale|October 23, 2016
[A model of care for first-episode psychosis: the RAISE-ETP project]J-M Azorin, M Adida, R Belzeaux, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|April 17, 2012
[Towards a new approach of neurophysiology in clinical psychiatry: functional magnetic resonance imaging neurofeedback applied to emotional dysfunctions]J-A Micoulaud-Franchi, E Fakra, M Cermolacce, et al.
L'Encephale|January 1, 2015
[Co-occuring mood and substance use disorders]M Adida, A Kaladjian, E Fakra, et al.
L'Encephale|January 3, 2013
[Emotional endophenotypes and bipolar disorder]M Dubois, J-M Azorin, E Fakra, et al.
L'Encephale|September 23, 2019
The clinical and economic impact of three-monthly long-acting formulation of paliperidone palmitate versus the one-monthly formulation in the treatment of schizophrenia in France: A cost-utility studyC H Arteaga Duarte, E Fakra, C Van Gils, et al.
L'Encephale|February 12, 2023
Deinstitutionalisation, community-based care and coercion: Did France learn from international experiences?Y Quenum, M Pulcini, C Morel-Prieur, et al.
L'Encephale|January 3, 2013
[Schizophrenic and bipolar endophenotypes: the clinician's point of view]M Cermolacce, E Fakra, R Belzeaux, et al.
Pageof 10

Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
L'Encephale|August 7, 2007
[Conceptualisation and validation of the "Emotional State Questionnaire (ESQ)": evaluation of an emotional profile]C Cassé-Perrot, E Fakra, E Jouve, et al.
L'Encephale|January 19, 2016
[Negative symptoms: clinical and psychometric aspects]M Adida, J-M Azorin, R Belzeaux, et al.
L'Encephale|January 19, 2016
[Negative symptoms, emotion and cognition in schizophrenia]E Fakra, R Belzeaux, J-M Azorin, et al.
L'Encephale|October 23, 2016
[A model of care for first-episode psychosis: the RAISE-ETP project]J-M Azorin, M Adida, R Belzeaux, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|April 17, 2012
[Towards a new approach of neurophysiology in clinical psychiatry: functional magnetic resonance imaging neurofeedback applied to emotional dysfunctions]J-A Micoulaud-Franchi, E Fakra, M Cermolacce, et al.
L'Encephale|January 1, 2015
[Co-occuring mood and substance use disorders]M Adida, A Kaladjian, E Fakra, et al.
L'Encephale|January 3, 2013
[Emotional endophenotypes and bipolar disorder]M Dubois, J-M Azorin, E Fakra, et al.
L'Encephale|September 23, 2019
The clinical and economic impact of three-monthly long-acting formulation of paliperidone palmitate versus the one-monthly formulation in the treatment of schizophrenia in France: A cost-utility studyC H Arteaga Duarte, E Fakra, C Van Gils, et al.
L'Encephale|February 12, 2023
Deinstitutionalisation, community-based care and coercion: Did France learn from international experiences?Y Quenum, M Pulcini, C Morel-Prieur, et al.
L'Encephale|January 3, 2013
[Schizophrenic and bipolar endophenotypes: the clinician's point of view]M Cermolacce, E Fakra, R Belzeaux, et al.
Pageof 10